Andrew Turley
FeatureThe dream of zeolite design
Zeolites are important industrial catalysts, so why can’t chemists make them to order? Andrew Turley finds out
PodcastCitric acid
If life hands you lemons, make lemonade – or you could make citric acid, a very useful commodity chemical according to Andrew Turley
ResearchCarbon nanotube-based sensor detects meat spoilage
Electron density of cobalt porphyrin complexes key to meat freshness sensor
Business23andMe jumps into drug R&D
Gene profiling firm aims to capitalise on its databank of genetic information to discover new drugs
BusinessAbbVie to buy Pharmacyclics for pipeline boost
$21bn deal gives AbbVie a share in sales of blockbuster cancer drug as its own biggest sellers face patent expiry
BusinessHepatitis C drug patent challenged in Europe
Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent
ResearchFish skin dressing helps heal wounds
Collagen fibres derived from the skin of tilapia fish supported faster wound healing in rats
ResearchEnzyme uses internal network for cyclisation
Researchers have pinpointed individual amino acid residues involved in the production of cyclic terpenes by a plant enzyme
- Business
DuPont and Monsanto settle Roundup dispute
Firms drop expensive ongoing litigation in favour of a licensing deal
- Business
Interpol teams up with pharma
Pharmaceutical crime programme will seek to reduce trade in fake drugs
- Business
Dow makes $1.5bn divestiture plans
Liveris in favour of ‘selectively pruning’ further non-core units
- Business
Dispute over Arkema finances
French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year
- Business
University to acquire Shell UK R&D site
Site at Thornton will become a science park under the stewardship of the University of Chester
- Business
Alcohol dependence pill approved in EU
Selincro tablets from Lundbeck designed to reduce consumption of alcohol
- Business
Dow rapped for $1bn tax scheme
Judge opines: ‘tax law deals in economic realities, not legal abstractions’
- Business
Does chemical regulation boost innovation?
Report suggests that supply of innovation responds to extra demand created by new laws
- Business
Talk of a $6.6bn deal for Elan
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
- Business
$595m octreotide deal grabs Roche
Company will get worldwide rights to oral formulation of growth hormone drug